Ananda Murali Rayapati

Mr. Ananda Murali Rayapati


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2025 in Viruses
Verified
Journal Article
Open access
PDF file
ARAnanda Murali Rayapati
Ananda Murali Rayapati
CCCHANDRASEKHAR CHANDA
CHANDRASEKHAR CHANDA
SPSudarsana Poojari
Sudarsana Poojari
BVBHADRA MURTHY VEMULAPATI
BHADRA MURTHY VEMULAPATI
Background and Objectives: Myricetin, a flavonoid compound, was demonstrated to effectively arrest the cell-to-cell fusion and syncytial development triggered by Nipah virus (NiV) fusion (F) and attachment (G) envelope glycoproteins in vitro involving two permissive mammalian cell lines. Methods: Time-of-addition assays were carried out using codon-optimized NiV wild type (WT) F and G plasmids followed by a challenge with the addition of myricetin 1 h and 6 h post-transfection in HEK 293T and Vero cells. Results: Upon evaluating different myricetin concentrations, it was determined that a 100 μM concentration of myricetin effectively inhibited 64–80% of syncytia in HEK and Vero cells. Interpretation & Conclusions: In this study, we concluded that myricetin mitigated the syncytial development in HEK and Vero cell lines. Given the flavonoid attributes of myricetin which is widely present in fruits, vegetables, tea, and wine, it may be regarded as a phytonutrient and a safer antiviral alternative against Nipah virus infections. Due to the BSL-4 nature of the virus, further research involving live virus culture is necessary to confirm myricetin as a potential antiviral compound for the mitigation of pathological effects of NiV infections.

29 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ARAnanda Murali Rayapati
Ananda Murali Rayapati
CCCHANDRASEKHAR CHANDA
CHANDRASEKHAR CHANDA
SPSudarsana Poojari
Sudarsana Poojari
BVBHADRA MURTHY VEMULAPATI
BHADRA MURTHY VEMULAPATI
Myricetin (MYR), a flavonoid demonstrated antiviral activity in effectively inhibiting nipah virus envelope glycoprotein mediated syncytial development in-vitro. Time-of-addition assays were designed to evaluate the effective concentration of MYR using codon-optimized NiV wild type (WT) F and G plasmids followed by the addition of MYR in HEK and vero cells. From the seven different concentrations tested, MYR was effective at 100μM concentration with a ~80% decline in syncytial count in HEK293T and vero cells. Results from the time-of-addition assays indicated that MYR might play a critical role in the reduction of NiV F and G glycoprotein expression levels and(or) interfere with their receptor binding, F and G interactions rendering the glycoproteins inefficient in cell-to-cell fusion leading to a quantifiable reduction in the syncytial development. This study is the first to determine antiviral potential of MYR in mitigating the effects of NiV pathogenesis in-vitro.